<DOC>
	<DOCNO>NCT02801604</DOCNO>
	<brief_summary>The practicality ADHD medication moderately examine long term routine condition . Therefore , multi-centre , multi-national prospective non-interventional study , recommend follow-up time 12 month investigate course therapy child adolescent ADHD prior MPH treatment medication change dexamfetamine several European country daily routine . It consist baseline visit MPH another ADHD drug therapy , change dexamfetamine , prospective description titration phase 12 month maintenance phase . Data use dexamfetamine routine clinical practice collect describe dexamfetamine prescribe , titrate used population ADHD patient factor influence general intensity ADHD safety event . This study collect real world data dexamfetamine compare descriptively general intensity ADHD accord ADHD classification impairment due ADHD therapy dexamfetamine general intensity ADHD accord ADHD classification impairment due ADHD prior therapy MPH . Furthermore utilization dexamfetamine assess regard treatment persistence , compliance , proportion patient discontinue treatment reason discontinuation . Due fact patient treat accord local medical practice possible medication change observation period .</brief_summary>
	<brief_title>Attentin® Children Adolescents With ADHD - A Non-interventional Study</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<criteria>Age ≥ 6 17.11 year Current MPH therapy insufficient ADHD classify accord validate classification system ( e.g . DSM ICD10 ) No contraindication dexamfetamine Contraindication dexamfetamine</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>215 Months</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>